Overview

Azithromycin Treatment of Patients With Chronic Obstructive Pulmonary Disease (COPD) and Tracheostomy

Status:
Terminated
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
Aims of the study - to evaluate the rate of enteric gram negative bacteria colonization in tracheotomised COPD patients - to evaluate the effect of azithromycin long-term treatment on Pseudomonas aeruginosa colonization and colony counts, and on reduction of the number of exacerbations/hospitalisations, antibiotic courses and steroid use. - to evaluate the Quality of Life of patients treated and not treated with azithromycin, using a validate Italian version of St George questionnaire - to evaluate the rate of chronic colonization with atypical pathogens - to evaluate the safety and tolerability of a long-term treatment with azithromycin, including a survey on possible bacterial antibiotic resistance pattern variations
Phase:
Phase 2
Details
Lead Sponsor:
University of Milan
Collaborator:
Pfizer
Treatments:
Azithromycin